L&C Bio Turns Profitable on RITOO Momentum as Conversion Risk Draws Attention

L&C Bio has turned profitable, supported by the strong performance of RITOO. According to hankyung.com, the main point of the analysis is that RITOO’s commercial momentum translated into improved earnings. However, the possible exercise of conversion rights was cited as a risk that could affect the share price and shareholder value. While the company’s earnings trend has improved, investors need to monitor whether conversion-related share supply may create pressure. Source: hankyung.com.